Michael Seimetz Selected Research

Michael Seimetz Research Topics

Disease

10	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 11/2013
9	Emphysema 11/2023 - 10/2011
9	Pulmonary Hypertension 11/2023 - 10/2011
5	Vascular Remodeling 01/2021 - 10/2011
3	Hypoxia (Hypoxemia) 01/2021 - 12/2013
3	Inflammation (Inflammations) 01/2021 - 01/2016
2	Lung Diseases (Lung Disease) 01/2016 - 03/2014
1	Infections 04/2022
1	Body Weight (Weight, Body) 01/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Dyslipidemias (Dyslipidemia) 09/2015
1	Atherosclerosis 09/2015
1	HIV Infections (HIV Infection) 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2015
1	Right Ventricular Hypertrophy 01/2015
1	Hypertension (High Blood Pressure) 02/2014
1	Sleep Apnea Syndromes (Sleep Apnea) 02/2014
1	Pulmonary Emphysema 11/2013
1	Glucose Intolerance 01/2013
1	Hypertrophy 01/2013

Drug/Important Bio-Agent (IBA)

11	SmokeIBA 11/2023 - 10/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2013
3	Superoxides (Superoxide)IBA 01/2020 - 11/2013
2	Pancreatic Elastase (Elastase)IBA 11/2023 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2020 - 01/2020
2	NADPH Oxidase 2IBA 01/2020 - 02/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2019
2	Soluble Guanylyl CyclaseIBA 01/2015 - 06/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2023
1	Fibroblast Growth Factor 10IBA 11/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2022
1	dalbavancinIBA 04/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	3-nitrotyrosineIBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	riociguatIBA 01/2019
1	Sodium Channels (Sodium Channel)IBA 01/2016
1	InflammasomesIBA 01/2016
1	CeramidesIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	CytokinesIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 10/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Carrier Proteins (Binding Protein)IBA 10/2015
1	Viral ProteinsIBA 09/2015
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2015
1	piclamilastIBA 01/2015
1	Tadalafil (Cialis)FDA Link 01/2015
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2015
1	Chymases (Chymase)IBA 03/2014
1	acetovanillone (apocynin)IBA 02/2014
1	NADPH Oxidase 1IBA 12/2013
1	MonocrotalineIBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2013
1	AnionsIBA 11/2013
1	mahuang-tangIBA 01/2013
1	Glucose Transporter Type 4IBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2013
2	Resistance Training 01/2016 - 01/2013
1	Lasers (Laser) 10/2015
1	Art Therapy 09/2015